Skip to content
OpenCapital
Get started

vTv Therapeutics VTVT Q1 2025 earnings

Reported May 15, 2025 · Before market open

Diluted EPS-$0.77Miss by $0.04
EPS estimate-$0.73

Next report

Aug 11, 2026 (In 4 weeks)
Revenue estimate$333.3K
EPS estimate-$0.97

Versus estimates

Revenue

Q1 2026$36.8MBeat by $16.8MQ4 2024$17.0K

Diluted EPS

Q1 2026$1.65Beat by $1.31Q4 2025-$0.58Beat by $0.40Q3 2025-$1.08Miss by $0.11Q2 2025-$0.92Miss by $0.07
Q1 2025-$0.77Miss by $0.04
Q4 2024-$0.55Beat by $0.32

Ask the moment vTv Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did vTv Therapeutics report Q1 2025 earnings?
vTv Therapeutics (VTVT) reported Q1 2025 earnings on May 15, 2025 before market open.
What were vTv Therapeutics's Q1 2025 revenue and EPS?
vTv Therapeutics reported diluted EPS of $-0.77 for Q1 2025.
Did vTv Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.73 by $0.04.
How did vTv Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 34.2% from $-1.17.
Where can I find vTv Therapeutics's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001641489-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.